Arrhythmias, Cardiac

• 

  Subject Areas on Research

  • 'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). 
  • 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. 
  • 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 
  • 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 
  • 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. 
  • 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. 
  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society. 
  • 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society. 
  • A Bedside Intervention to Treat Ventricular Arrhythmias: Procedural Advances and Safety Considerations. 
  • A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response. 
  • A comparison of paramedic versus basic emergency medical care of patients at high and low risk during acute myocardial infarction. 
  • A controlled trial of acute effects of human exposure to traffic particles on pulmonary oxidative stress and heart rate variability. 
  • A mouse model of congenital heart disease: cardiac arrhythmias and atrial septal defect caused by haploinsufficiency of the cardiac transcription factor Csx/Nkx2.5. 
  • A new approach for analysis of heart rate variability and QT variability in long-term ECG recording. 
  • A novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmias. 
  • A pilot study using an implantable device to characterize cardiac arrhythmias in hemodialysis patients: implications for future research. 
  • A proarrhythmic response to sodium channel blockade: modulation of the vulnerable period in guinea pig ventricular myocardium. 
  • A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes. 
  • A space-time adaptive method for simulating complex cardiac dynamics. 
  • A theoretical analysis of acute ischemia and infarction using ECG reconstruction on a 2-D model of myocardium. 
  • A three-dimensional finite element model of radiofrequency ablation with blood flow and its experimental validation. 
  • A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker. 
  • ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). 
  • ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. 
  • ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. 
  • ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. 
  • ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. 
  • ACR Appropriateness Criteria® Dyspnea-Suspected Cardiac Origin. 
  • AHA scientific statement: practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association Scientific Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized electrocardiology and the American Association of Critical-Care Nurses. 
  • ATP1A3-Encoded Sodium-Potassium ATPase Subunit Alpha 3 D801N Variant Is Associated With Shortened QT Interval and Predisposition to Ventricular Fibrillation Preceded by Bradycardia. 
  • Action potential and QT prolongation not sufficient to cause Torsade de Pointes: role of action potential triangulation. 
  • Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks. 
  • Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation does not worsen neurologic outcome. 
  • Administration of thrombolytic therapy in the community hospital: established principles and unresolved issues. 
  • Adverse effects of corticosteroids on the cardiovascular system. 
  • Adverse outcomes associated with postoperative atrial arrhythmias after lung transplantation: A meta-analysis and systematic review of the literature. 
  • Amiodarone hepatotoxicity simulating alcoholic liver disease. 
  • An interaction between the III-IV linker and CTD in NaV1.5 confers regulation of inactivation by CaM and FHF. 
  • Analysis of cardiac arrhythmias during dobutamine pharmacologic stress testing in nuclear cardiology as related to the presence or absence of baseline arrhythmias. 
  • Analysis of first-derivative based QRS detection algorithms. 
  • Angiotensin converting enzyme inhibitors and the cardiovascular system. 
  • Ankyrin-G coordinates intercalated disc signaling platform to regulate cardiac excitability in vivo. 
  • Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting. 
  • Anorexia nervosa and second-degree atrioventricular block (Type I). 
  • Antiarrhythmic agents in older patients. Current state of knowledge. 
  • Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). 
  • Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm. 
  • Anxiety reduces baroreflex cardiac control in older adults with major depression. 
  • Arrhythmia prophylaxis using propranolol after coronary artery surgery. 
  • Arrhythmias Requiring ECMO in Infants Without Structural Congenital Heart Disease. 
  • Arrhythmias in 2016: Arrhythmia treatment - evidence catching up with technology. 
  • Arrhythmias in Female Patients: Incidence, Presentation and Management. 
  • Arrhythmias in a contemporary fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study. 
  • Arrhythmias in children having a single left superior vena cava and minimal structural heart disease. 
  • Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease. 
  • Arrhythmias in patients with hypoplastic left heart syndrome. 
  • Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary ICD Therapy. 
  • Arrhythmogenic epilepsy: an hypothesis. 
  • Arrhythmogenic right ventricular dysplasia: a United States experience. 
  • Artificial Intelligence and Machine Learning in Arrhythmias and Cardiac Electrophysiology. 
  • Association between n-3 fatty acid consumption and ventricular ectopy after myocardial infarction. 
  • Atrial arrhythmias after pulmonary thromboendarterectomy. 
  • Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). 
  • Atrioventricular and ventricular-to-ventricular programming in patients with cardiac resynchronization therapy: results from ALTITUDE. 
  • Audible implantable cardioverter defibrillator alarms detect intermittent conductor discontinuity. 
  • Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias. 
  • Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial. 
  • Baseline fragmented QRS increases the risk of major arrhythmic events in Brugada syndrome: Systematic review and meta-analysis. 
  • Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure. 
  • Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS. 
  • Burden and Impact of Arrhythmias in Repaired Tetralogy of Fallot. 
  • Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury. 
  • Calcium Channel Mutations in Cardiac Arrhythmia Syndromes. 
  • Calcium Signaling and Cardiac Arrhythmias. 
  • Calmodulin limits pathogenic Na+ channel persistent current. 
  • Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy. 
  • Cannabis use disorder and increased risk of arrhythmia-related hospitalization in young adults. 
  • Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia. 
  • Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis. 
  • Cardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic Cardiomyopathy. 
  • Cardiac Surgery in Patients With Trisomy 13 and 18: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database. 
  • Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series. 
  • Cardiac conduction abnormalities in endocarditis defined by the Duke criteria. 
  • Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium. 
  • Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction. 
  • Cardiac dysregulation following intrahippocampal kainate-induced status epilepticus. 
  • Cardiac evaluation for structural abnormalities may not be required in patients presenting with syncope and a normal ECG result in an observation unit setting. 
  • Cardiac ion channels. 
  • Cardiac renin-angiotensin system. Molecular and functional aspects. 
  • Cardiac repolarization instability during normal postnatal development. 
  • Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. 
  • Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management. 
  • Cardiovascular Implantable Electronic Device Surgery Following Left Ventricular Assist Device Implantation. 
  • Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. 
  • Centers for Medicare and Medicaid Services' Decision to Reconsider Coverage Indications for ICDs: Where to Now? 
  • Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) Pilot Study. 
  • Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. 
  • Chest pain in the adolescent and young adult. 
  • Classification of 12-lead ECGs: the PhysioNet/Computing in Cardiology Challenge 2020. 
  • Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review. 
  • Clinical and echocardiographic characteristics of patients with mitral anular calcification. Comparison with age- and sex-matched control subjects. 
  • Clinical cardiac electrophysiology fellowship teaching objectives for the new millennium. 
  • Clinical correlates of atrial tachyarrhythmias after valve replacement for aortic stenosis. 
  • Clinical features of Wolff-Parkinson-White syndrome. 
  • Cocaine-mediated impairment of cardiac conduction in the dog: a potential mechanism for sudden death after cocaine. 
  • Collision-based spiral acceleration in cardiac media: roles of wavefront curvature and excitable gap. 
  • Combination ethacizin and ethmozin treatment of resistant ventricular ectopy: theoretical, experimental, and clinical study. 
  • Combinations of beta-blockers and calcium channel blockers: a cause of malignant perioperative conduction disturbances? 
  • Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants. 
  • Common human ANK2 variant confers in vivo arrhythmia phenotypes. 
  • Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment. 
  • Comparative pharmacodynamics of intravenous lidocaine in patients with acute and chronic ventricular arrhythmias. 
  • Comparison of Fontan survivors with and without pacemakers: a report from the Pediatric Heart Network Fontan Cross-Sectional Study. 
  • Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE. 
  • Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction. 
  • Computerized system for isochronic epicardial mapping 
  • Conditional knockout of Fgf13 in murine hearts increases arrhythmia susceptibility and reveals novel ion channel modulatory roles. 
  • Conduction block in micropatterned cardiomyocyte cultures replicating the structure of ventricular cross-sections. 
  • Conduction defects and mitral annulus calcification. 
  • Congenital heart disease and pulmonary hypertension. 
  • Contrast M-mode ultrasonography of the inferior vena cava. 
  • Control of electrical alternans in simulations of paced myocardium using extended time-delay autosynchronization. 
  • Controversies and Challenges of Ventricular Assist Device Therapy. 
  • Criteria for early discharge after acute myocardial infarction: validation in a community hospital. 
  • Critical arrhythmia associated with pulmonary artery catheterization in a parturient with severe pulmonary hypertension. 
  • Critical reviews in basic electrophysiology: realizing the synergy between the basic and clinical sciences. 
  • Cryosurgery for cardiac arrhythmias: acute and chronic effects on coronary arteries. 
  • Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database. 
  • Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative. 
  • Current view on regulation of voltage-gated sodium channels by calcium and auxiliary proteins. 
  • DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. 
  • Dealing with the highs and lows of contrast agents in left main disease. 
  • Depression and ischemic heart disease: what have we learned so far and what must we do in the future? 
  • Design and implementation of a new computerized system for intraoperative cardiac mapping. 
  • Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients. 
  • Design of a modular, extensible decision support system for arrhythmia therapy. 
  • Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network. 
  • Dialysate potassium concentration: Should mass balance trump electrophysiology? 
  • Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B. 
  • Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. 
  • Disproportionate costs and charges for pediatric catheter ablation: supply and demand... or just supply? 
  • Dissection of a quantitative trait locus for PR interval duration identifies Tnni3k as a novel modulator of cardiac conduction. 
  • Distributed decision support using a web-based interface: prevention of sudden cardiac death. 
  • Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission? 
  • Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias. 
  • ECG quantification of myocardial scar and risk stratification in MADIT-II. 
  • EKG abnormalities in pediatric patients with myotonic dystrophy. 
  • Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction. 
  • Editorial commentary: Harm from left bundle branch block: We are the tortoise, not the hare. 
  • Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial. 
  • Effect of Remote Cardiac Monitoring System Design on Response Time to Critical Arrhythmias. 
  • Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial. 
  • Effects of electroacupuncture on gastric motility and heart rate variability in conscious rats. 
  • Effects of peroneal nerve stimulation on hypothalamic stimulation-induced ventricular arrhythmias in rabbits. 
  • Efficacy of zoniporide, an Na/H exchange ion inhibitor, for reducing perioperative cardiovascular events in vascular surgery patients. 
  • Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association. 
  • Electrocardiographic assessment for therapeutic proteins--scientific discussion. 
  • Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy. 
  • Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. 
  • Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction. 
  • Electrophysiologic testing to identify patients at risk for sudden death. 
  • Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. 
  • Electrophysiological mechanisms of the anti-arrhythmic effects of omega-3 fatty acids. 
  • Electrophysiology in China: a special supplement. Introduction. 
  • Emergency room and inpatient use after cardiac pacemaker implantation. 
  • Emerging class III antiarrhythmic agents: mechanism of action and proarrhythmic potential. 
  • Emerging topics in electrophysiology. 
  • Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy. 
  • Epidemiology and Outcomes Associated with PR Prolongation. 
  • Epidemiology, evaluation, and management of conduction disturbances after transcatheter aortic valve replacement. 
  • Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. 
  • Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. 
  • European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). 
  • Evaluation of Selvester QRS score for use in presence of conduction abnormalities in a broad population. 
  • Evaluation of T-Wave Morphology in Patients With Left Bundle Branch Block and Suspected Acute Coronary Syndrome. 
  • Evaluation of left ventricular mechanical dyssynchrony as determined by phase analysis of ECG-gated SPECT myocardial perfusion imaging in patients with left ventricular dysfunction and conduction disturbances. 
  • Evaluation of the dofetilide risk-management program. 
  • Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development. 
  • Examination of QTc Values in Critically Ill Patients Diagnosed with Delirium and Prescribed Atypical Antipsychotics. 
  • Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. 
  • Existence of bistability and correlation with arrhythmogenesis in paced sheep atria. 
  • Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"? 
  • Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction. 
  • Extracellular potentials related to intracellular action potentials in the dog Purkinje system. 
  • Extracorporeal Membrane Oxygenation for Hemodynamic Support. 
  • Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. 
  • Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. 
  • Feedback-control induced pattern formation in cardiac myocytes: a mathematical modeling study. 
  • Fetal echocardiography and fetal cardiology: indications, diagnosis and management. 
  • Fibroblast growth factor homologous factors in the heart: a potential locus for cardiac arrhythmias. 
  • Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding-deficient channels. 
  • Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. 
  • Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants. 
  • Functional status, heart rate, and rhythm abnormalities in 521 Fontan patients 6 to 18 years of age. 
  • GENESIS: Gene-Specific Machine Learning Models for Variants of Uncertain Significance Found in Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome-Associated Genes. 
  • Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association. 
  • Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways. 
  • Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. 
  • Genetics of cardiac repolarization. 
  • Genome-wide association studies of the PR interval in African Americans. 
  • Gi alpha 1-mediated cardiac electrophysiological remodeling and arrhythmia in hypertrophic cardiomyopathy. 
  • HRS White Paper on interoperability of data from cardiac implantable electronic devices (CIEDs). 
  • HRS/ACCF expert consensus statement on pacemaker device and mode selection. 
  • HRS/ACCF expert consensus statement on pacemaker device and mode selection. Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons. 
  • Have the results of randomized clinical trials of pacing altered the practice of cardiac pacing? 
  • Heart rate and metabolic response to competitive squash in veteran players: identification of risk factors for sudden cardiac death. 
  • Hereditary long Q-T syndrome presenting as epilepsy: electroencephalography laboratory diagnosis. 
  • Hereditary progressive atrioventricular conduction defect. A new syndrome? 
  • High prevalence of symptomatic bradyarrhythmias due to atrioventricular node-fascicular and sinus node-atrial disease in patients with mitral anular calcification. 
  • High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays. 
  • Highlights of Heart Rhythm 2004, the Annual Scientific Sessions of the Heart Rhythm Society: May 19 to 22, 2004, in San Francisco, California. 
  • Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, Louisiana. 
  • Home automated external defibrillators in a geriatric population: a brief discussion of the evidence. 
  • How to handle myasthenic crisis. Essential steps in patient care. 
  • Hypercalcemia-induced ST-segment elevation mimicking acute myocardial infarction. 
  • Hyperkalemia: treatment options. 
  • Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. 
  • Images in cardiovascular medicine. Left ventricular apical pseudoaneurysm: echocardiographic and intraoperative findings. 
  • Images in cardiovascular medicine: in vivo imaging of the adult Drosophila melanogaster heart with real-time optical coherence tomography. 
  • Impact of interruptions in radiofrequency energy delivery on lesion characteristics. 
  • Impact of peer review in reduction of permanent pacemaker implantations. 
  • Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis. 
  • Implantable cardioverter defibrillators in Israel: utilization and implantation trends. 
  • Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. 
  • Implantable cardioverter defibrillators: risks accompany the life-saving benefits. 
  • Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions. 
  • Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation. 
  • Implantable cardioverter-defibrillators for primary prevention: how do the data pertain to the aged? 
  • Implications of atypical antipsychotic prescribing in the intensive care unit. 
  • Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream". 
  • In vitro discovery of novel prokaryotic ion channel candidates for antiarrhythmic gene therapy. 
  • In vitro temperature map of cardiac ablation demonstrates the effect of flow on lesion development. 
  • Incidence and severity of acute complications after spinal cord injury. 
  • Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. 
  • Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study. 
  • Increasing the computational efficiency of a bidomain model of defibrillation using a time-dependent activating function. 
  • Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. 
  • Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. 
  • Insights on the robust variance estimator under recurrent-events model. 
  • Is mortality a useful parameter for public reporting in pacemaker implantation? Results of an obligatory external quality control programme. 
  • Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study. 
  • Junctophilin-2 at the intersection of arrhythmia and pathologic cardiac remodeling. 
  • Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. 
  • Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker. 
  • Left Bundle Branch Block Before Transcatheter Aortic Valve Replacement. 
  • Left Bundle Branch Block: Is it "Unsafe at Any Speed"? 
  • Letter to the editor. 
  • Life-threatening dysrhythmias in varicella myocarditis. 
  • Localization of the site of ventricular premature complexes by radionuclide angiographic phase imaging. 
  • Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. 
  • Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium. 
  • Long-term mortality in patients with pauses in ventricular electrical activity. 
  • Long-term prognosis associated with J-point elevation in a large middle-aged biracial cohort: the ARIC study. 
  • Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients. 
  • Loss of efficacy during long-term cifenline therapy: development of antiarrhythmic resistance? 
  • MRI for the assessment of myocardial viability. 
  • Magnesium: physiology and pharmacology. 
  • Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Associated With Cardiac Channelopathies. 
  • Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Related to Ischemic and Nonischemic Cardiomyopathy. 
  • Management of fetal cardiac arrhythmias. 
  • Management of pediatric tachyarrhythmias on mechanical support. 
  • Mandatory diagnostic screening tests to individualize therapy: a curious paradox. 
  • Mechanical dyssynchrony evaluated by tissue Doppler cross-correlation analysis is associated with long-term survival in patients after cardiac resynchronization therapy. 
  • Mechanical dyssynchrony: How do we measure it, what it means, and what we can do about it. 
  • Mechanism of ventricular vulnerability to single premature stimuli in open-chest dogs. 
  • Mechanisms of action of antiarrhythmic drugs: from ion channel blockage to arrhythmia termination. 
  • Mechanoelectrical excitation by fluid jets in monolayers of cultured cardiac myocytes. 
  • Medical Management of Patients With a Left Ventricular Assist Device for the Non-Left Ventricular Assist Device Specialist. 
  • Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment. 
  • Microheterogeneity-induced conduction slowing and wavefront collisions govern macroscopic conduction behavior: A computational and experimental study. 
  • Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. 
  • Modeling atrial arrhythmias: impact on clinical diagnosis and therapies. 
  • Molecular biology of sodium channels and their role in cardiac arrhythmias. 
  • Monitoring significant ST changes through deep learning. 
  • Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker. 
  • Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. 
  • Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias. 
  • Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol. 
  • Multiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5A. 
  • My child needs or has an implantable cardioverter-defibrillator: what should I do? 
  • Myocardial infarction and stroke. 
  • Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial. 
  • Neonate with coxsackie B1 infection, cardiomyopathy and arrhythmias. 
  • New catheter techniques for analysis of the sequence of retrograde atrial activation in man. 
  • New directions in clinical outcomes assessment : VIth International Symposium on Interventional Electrophysiology in the Management of Cardiac Arrhythmias. 
  • Novel Brugada SCN5A mutation causing sudden death in children. 
  • Novel anisotropic engineered cardiac tissues: studies of electrical propagation. 
  • Novel electrocardiogram configurations and transmission procedures in the prehospital setting: effect on ischemia and arrhythmia determination. 
  • Obesity and dysrhythmias. 
  • On the mechanism of action of antiarrhythmic agents. 
  • Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis. 
  • Origin of body surface QRS and T wave potentials from epicardial potential distributions in the intact chimpanzee. 
  • Origin of epicardial ST-T wave potentials in the intact dog. 
  • Panoramic display of the orderly sequenced 12-lead ECG. 
  • Pathogenicity Assignment of Variants in Genes Associated With Cardiac Channelopathies Evolve Toward Diagnostic Uncertainty. 
  • Patient load effects on response time to critical arrhythmias in cardiac telemetry: a randomized trial. 
  • Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®. 
  • Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. 
  • Perioperative cardiac arrhythmias. 
  • Perioperative cardiac complications and 30-day mortality in patients undergoing intracranial aneurysmal surgery with adenosine-induced flow arrest: a retrospective comparative study. 
  • Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans. 
  • Posterior capsular injections of ropivacaine during total knee arthroplasty: a randomized, double-blind, placebo-controlled study. 
  • Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. 
  • Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses. 
  • Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction. 
  • Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score. 
  • Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. 
  • Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score. 
  • Predicting the outcomes of electrophysiologic studies of patients with unexplained syncope: preliminary validation of a derived model. 
  • Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. 
  • Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy. 
  • Predisposition to arrhythmias: electrolytes, uremic fibrosis, other factors. 
  • Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy. 
  • Presentation and explanation of medical decision models using the World Wide Web. 
  • Prevalence and Phenotypic Burden of Monogenic Arrhythmias Using Integration of Electronic Health Records With Genetics. 
  • Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. 
  • Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). 
  • Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial. 
  • Prinzmetal's angina, normal coronary arteries and pericarditis. 
  • Priorities for comparative effectiveness reviews in cardiovascular disease. 
  • Proarrhythmia of azimilide and other class III antiarrhythmic agents in the adrenergically stimulated rabbit. 
  • Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments. 
  • Procainamide-induced sinus node dysfunction in patients with chronic renal failure. 
  • Prognostic effect of bundle branch block related to coronary artery bypass grafting. 
  • Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease. 
  • Prognostic significance of exercise-induced complex ventricular arrhythmias in coronary artery disease with normal and abnormal left ventricular ejection fraction. 
  • Prognostic value of ventricular arrhythmias associated with treadmill exercise testing in patients studied with cardiac catheterization for suspected ischemic heart disease. 
  • Propafenone: an effective agent for the management of supraventricular arrhythmias. 
  • Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. 
  • Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. 
  • Prophylaxis against postoperative atrial fibrillation: current progress and future directions. 
  • Proton pump inhibitors and hypomagnesemia in patients with arrhythmias. 
  • QRS duration in patients hospitalized for worsening heart failure. 
  • QTc monitoring in adults with medical and psychiatric comorbidities: Expert consensus from the Association of Medicine and Psychiatry. 
  • Quality improvement in heart rhythm care: the path forward. 
  • Quantitative analysis of QRS detection algorithms based on the first derivative of the ECG. 
  • Racial and ethnic disparities in arrhythmia care: A call for action. 
  • Radiographic manifestations of cardiac sarcoid. 
  • Rationale and design of the Duke Electrophysiology Genetic and Genomic Studies (EPGEN) biorepository. 
  • Real-Time Cardiac Arrhythmia Classification Using Memristor Neuromorphic Computing System. 
  • Recent advances in the treatment of arrhythmias. 
  • Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association. 
  • Recurrence of local anesthetic cardiac toxicity or hypokalemia? 
  • Redox-Active Drug, MnTE-2-PyP5+, Prevents and Treats Cardiac Arrhythmias Preserving Heart Contractile Function. 
  • Reduced reperfusion-induced Ins(1,4,5)P3 generation and arrhythmias in hearts expressing constitutively active alpha1B-adrenergic receptors. 
  • Reducing hospital morbidity and mortality following esophagectomy. 
  • Relation between premature ventricular contraction site of origin (defined by radionuclide phase analysis) and subsequent left ventricular function. 
  • Relation of Norwood Shunt Type and Frequency of Arrhythmias at 6 Years (from the Single Ventricle Reconstruction Trial). 
  • Relationship Between Electrical and Mechanical Dyssynchrony and Outcomes Among Patients Undergoing Cardiac Resynchronization Therapy. 
  • Relationship between extracellular T-wave height, T-wave alternans amplitude, and tissue action potential alternans: a 1-dimensional computer modeling study. 
  • Relationship between serum quinidine concentration and quinidine dosage. 
  • Relationship between ventricular repolarization parameters and the inducibility of ventricular arrhythmias during electrophysiological study in patients with coronary artery disease. 
  • Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. 
  • Renal Dysfunction and Arrhythmia Association in Patients Receiving Milrinone After Cardiac Surgery. 
  • Renal denervation for the treatment of ventricular arrhythmias: A systematic review and meta-analysis. 
  • Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction. 
  • Respiratory motion and cardiac arrhythmia effects on diagnostic accuracy of myocardial delayed-enhanced MR imaging in canines. 
  • Response by Friedman and Al-Khatib to Letter Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry". 
  • Restitution in mapping models with an arbitrary amount of memory. 
  • Retreatment with digoxin immune Fab. 
  • Return of calcium: manipulating intracellular calcium to prevent cardiac pathologies. 
  • Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. 
  • Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis. 
  • Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis. 
  • Role of Mahaim fibers in cardiac arrhythmias in man. 
  • Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. 
  • Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure. 
  • SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death. 
  • SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia. 
  • STIM1-Ca2+ signaling in coronary sinus cardiomyocytes contributes to interatrial conduction. 
  • Safety of patients reason for FDA black box warning on droperidol. 
  • Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis. 
  • Selecting an antiarrhythmic agent for atrial fibrillation should be a patient-specific, data-driven decision. 
  • Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. 
  • Several new considerations in mitral valve repair. 
  • Sex Differences in Sustained Ventricular Arrhythmias: A Continuing Dialogue. 
  • Solution structure of the NaV1.2 C-terminal EF-hand domain. 
  • Spatial heterogeneity of restitution properties and the onset of alternans. 
  • Spironolactone and Cardiac Arrhythmias in Hemodialysis Patients: Helpful or Harmful? 
  • Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. 
  • Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias. 
  • Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias. 
  • Sudden Cardiac Death Among Hemodialysis Patients. 
  • Sudden cardiac death in patients with myocarditis: Evaluation, risk stratification, and management. 
  • Supraventricular conduction abnormalities following cardiac operations. A complication of inadequate atrial preservation. 
  • Surrogate end points in heart failure trials. 
  • Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. 
  • Sympathectomy in the treatment of angina and arrhythmias. 
  • Synergistic effects of exposure to concentrated ambient fine pollution particles and nitrogen dioxide in humans. 
  • T wave alternans: a marker of myocardial instability. 
  • Task Force 7: arrhythmias. 
  • Temperature-controlled and constant-power radio-frequency ablation: what affects lesion growth? 
  • Temporal Trends in and Factors Associated With Use of Single- Versus Dual-Coil Implantable Cardioverter-Defibrillator Leads: Data From the NCDR ICD Registry. 
  • The Association of Kidney Function and Albuminuria With the Risk and Outcomes of Syncope: A Population-Based Cohort Study. 
  • The Burden of Congestion in Patients Hospitalized With Acute Decompensated Heart Failure. 
  • The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). 
  • The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management: executive summary this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). 
  • The J wave patterns and risk of sudden cardiac death in patients with coronary artery disease. 
  • The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. 
  • The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction. 
  • The Society of Thoracic Surgeons Mitral Repair/Replacement Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force. 
  • The anatomic and electrical location of the left ventricular lead predicts ventricular arrhythmia in cardiac resynchronization therapy. 
  • The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. 
  • The assumptions of isochronal cardiac mapping. 
  • The cardiac vulnerable period and reentrant arrhythmias: targets of anti- and proarrhythmic processes. 
  • The changing epidemiology of ventricular arrhythmias and sudden cardiac death: Is it a reality? 
  • The course of acute myocardial infarction. Feasibility of early discharge of the uncomplicated patient. 
  • The effect of bretylium tosylate on ventricular function. 
  • The genetics of the J wave patterns. 
  • The high cost of implantable defibrillators. 
  • The impact of arrhythmias in acute heart failure. 
  • The incidence of seizures in patients undergoing therapeutic hypothermia after resuscitation from cardiac arrest. 
  • The interplay between CKD, sudden cardiac death, and ventricular arrhythmias. 
  • The interplay between autonomic tone and atrial arrhythmias. 
  • The pathophysiology of acute heart failure--is it all about fluid accumulation? 
  • The perplexing complexity of cardiac arrhythmias: beyond electrical remodeling. 
  • The preexcitation syndromes. 
  • The probability of defibrillation success and the incidence of postshock arrhythmia as a function of shock strength. 
  • The role of intrinsic and induced vulnerability in electrically induced cardiac arrhythmias. 
  • The spectrum of complications following left ventricular assist device placement. 
  • The subcutaneous implantable cardioverter-defibrillator in review. 
  • The usefulness of T-wave peak to T-wave end interval in identifying malignant arrhythmias in patients with Chagas disease. 
  • The variability of the electrical properties of the pulmonary veins. 
  • There should be a threshold dose for the FDA black-box warning on droperidol. 
  • Third universal definition of myocardial infarction. 
  • Time-dependent risk of Fidelis lead failure. 
  • Tocainide kinetics in congestive heart failure. 
  • Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias. 
  • Total shoulder arthroplasty in patients with HIV infection: complications, comorbidities, and trends. 
  • Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization. 
  • Treating cardiac dysrhythmias by targeting the neck: Off target or on the right track? 
  • Treating shock--old drugs, new ideas. 
  • Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. 
  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. 
  • Usefulness of frequent arrhythmias after epicardial recanalization in anterior wall acute myocardial infarction as a marker of cellular injury leading to poor recovery of left ventricular function. 
  • Utility of Cardiac Magnetic Resonance Imaging in Predicting Atrial Arrhythmias in Repaired Tetralogy of Fallot. 
  • Ventricular fibrillation in the Wolff-Parkinson-White syndrome. 
  • Very low calorie diets: their efficacy, safety, and future. 
  • Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice. 
  • Vulnerability in an excitable medium: analytical and numerical studies of initiating unidirectional propagation. 
  • Wavelet formation in excitable cardiac tissue: the role of wavefront-obstacle interactions in initiating high-frequency fibrillatory-like arrhythmias. 
  • What happens when cardiac Na channels lose their function? 1--numerical studies of the vulnerable period in tissue expressing mutant channels. 
  • [A case of acute poisoning from aconitine with cardiac rhythm disorders]. 
  • [Quantitative analysis of variability of electrocardiograms typical for polymorphic arrhythmias] 
  • [The combined effect of 2 first-line anti-arrhythmia drugs on the conduction velocity of myocardial stimulation]. 
• 

  Keywords of People

  • Barker, Piers Christopher Andrew, Professor of Pediatrics, Pediatrics, Cardiology
  • Bennett, Vann, George Barth Geller Distinguished Professor of Molecular Biology, Duke Cancer Institute
  • Bursac, Nenad, Professor of Biomedical Engineering, Biomedical Engineering
  • Carboni, Michael Paul, Associate Professor of Pediatrics, Pediatrics, Cardiology
  • Henriquez, Craig S., Professor of Biomedical Engineering, Biomedical Engineering
  • Mentz, Robert John, Associate Professor of Medicine, Medicine, Cardiology
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Milazzo Jr., Angelo Stephen, Professor of Pediatrics, Pediatrics
  • Neu, Wanda Krassowska, Professor Emeritus of Biomedical Engineering, Biomedical Engineering
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Pitt, Geoffrey Stuart, Adjunct Professor in the Department of Medicine, Medicine, Cardiology
  • Starmer, Charles Franklin, Professor Emeritus of Computer Science, Computer Science
  • Taekman, Jeffrey Marc, Professor Emeritus of Anesthesiology, Anesthesiology, Neuroanesthesia
  • Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine